Clinical Trial Update: A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety and tolerability of long-term UCB0107 administration in participants with Progressive Supranuclear Palsy; the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• UCB0107

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Progressive Supranuclear Palsy | Phase 1 | Status: ACTIVE_NOT_RECRUITING